Explore the vast range of titles available.

This convenient reference provides clinicians with point-of-care guidance to help their patients stop using tobacco- and nicotine-containing products--as well as the latest clinical data to encourage them to never start.

This convenient reference provides clinicians with point-of-care guidance to help their patients stop using tobacco- and nicotine-containing products--as well as the latest clinical data to encourage them to never start.CONTENTS CONSIST OF Nicotine-Containing Products Tobacco Use Disorder/Adverse Effects Prevention and Treatment Withdrawal Management, With and Without Medication Policy and Resources.

Smoking tobacco presents serious social problems with major impacts on public health. It is estimated that 25-30% of the general population in western countries are currently smoking. Tobacco use is the major preventable cause of death in the United States, responsible for more than 400,000 deaths annually. Within the USA and Europe, 70% of all smokers have tried to quit smoking at least once, but only about 6% of these succeeded in maintaining abstinence. This book covers the latest nicotine-related research. The selection of chapters has a certain unity as physiologic, pathologic and psychological themes run through the book and supply the logical connections between the various authors. This work is intended as a contribution to the reversal of the current tobacco epidemic and thereby to preventing many of the deaths attributable to tobacco predicted in this century.

Rationale Electronic cigarettes are becoming increasingly popular among smokers worldwide. Commonly reported reasons for use include the following: to quit smoking, to avoid relapse, to reduce urge to smoke, or as a perceived lower-risk alternative to smoking. Few studies, however, have explored whether electronic cigarettes (e-cigarettes) deliver measurable levels of nicotine to the blood. Objective This study aims to explore in experienced users the effect of using an 18-mg/ml nicotine first-generation e-cigarette on blood nicotine, tobacco withdrawal symptoms, and urge to smoke. Methods Fourteen regular e-cigarette users (three females), who are abstinent from smoking and e-cigarette use for 12 h, each completed a 2.5 h testing session. Blood was sampled, and questionnaires were completed (tobacco-related withdrawal symptoms, urge to smoke, positive and negative subjective effects) at four stages: baseline, 10 puffs, 60 min of ad lib use and a 60-min rest period. Results Complete sets of blood were obtained from seven participants. Plasma nicotine concentration rose significantly from a mean of 0.74 ng/ml at baseline to 6.77 ng/ml 10 min after 10 puffs, reaching a mean maximum of 13.91 ng/ml by the end of the ad lib puffing period. Tobacco-related withdrawal symptoms and urge to smoke were significantly reduced; direct positive effects were strongly endorsed, and there was very low reporting of adverse effects. Conclusions These findings demonstrate reliable blood nicotine delivery after the acute use of this brand/model of e-cigarette in a sample of regular users. Future studies might usefully quantify nicotine delivery in relation to inhalation technique and the relationship with successful smoking cessation/harm reduction.

About the Book: Smoking is injurious to health. It has been estimated that about 1.3 billion are addicted to smoking and unless steps are taken to make people aware of the growing menace, 650 million people are likely to die prematurely due to the extensive use of tobacco. The book, Tobacco Use: Health and Behaviour, in twelve chapters, deals with a wide range of issues concerning its cultivation and its impact on the health of its users. It provides a critical test for our concepts of reality; discusses how it has assumed political, economic and medical importance since its introduction; magnitude of its use and its global trend; how the sophisticated, wealthy and powerful drug cartel, based on the western world, is dictating its availability in the developing countries; its effect and its addiction potential; and the treatment of tobacco cessation. It is a valuable book to understand the use of tobacco, and plan strategies to curb the growing menace. It is meant for students and practitioners of public health, community and preventive medicine, psychiatry, psychology and those involved in the study and planning in the field of addiction, particularly tobacco addiction. Contents: Introduction History of Tobacco Use: New World`s Revenge Global Trends in Tobacco Use Tobacco: Cultivation, Curing and Commerce Nicotine: Pharmacokinetics, Metabolism and Pharmacodynamics Addiction Model: Tobacco Use as Drug Dependence People at Risk: Initiation and Maintenance of Tobacco Use Women and Children: Victims of Passive Smoking Tobacco Use and Medical Morbidity Tobacco Use in Psychiatric Patients Smoking-Cessation and Treatment of Tobacco Dependence Tobacco Control in India Tobacco Use: 2020 and Beyond Index.

In recent years, the scientific community has begun tо explore the efficacy оf an integrated neurofeedback + biofeedback approach іn various conditions, both pathological and non-pathological. Although several studies have contributed valuable insights into its potential benefits, this review aims tо further investigate its effectiveness by synthesizing current findings and identifying areas for future research. Our goal іs tо provide a comprehensive overview that may highlight gaps іn the existing literature and propose directions for subsequent studies. The search for articles was conducted on the digital databases PubMed, Scopus, and Web of Science. Studies to have used the integrated neurofeedback + biofeedback approach published between 2014 and 2023 and reviews to have analyzed the efficacy of neurofeedback and biofeedback, separately, related to the same time interval and topics were selected. The search identified five studies compatible with the objectives of the review, related to several conditions: nicotine addiction, sports performance, Autism Spectrum Disorder (ASD), and Attention Deficit Hyperactivity Disorder (ADHD). The integrated neurofeedback + biofeedback approach has been shown to be effective in improving several aspects of these conditions, such as a reduction in the presence of psychiatric symptoms, anxiety, depression, and withdrawal symptoms and an increase in self-esteem in smokers; improvements in communication, imitation, social/cognitive awareness, and social behavior in ASD subjects; improvements in attention, alertness, and reaction time in sports champions; and improvements in attention and inhibitory control in ADHD subjects. Further research, characterized by greater methodological rigor, is therefore needed to determine the effectiveness of this method and the superiority, if any, of this type of training over the single administration of either. This review іs intended tо serve as a catalyst for future research, signaling promising directions for the advancement оf biofeedback and neurofeedback methodologies.

To identify genetic variants associated with greater tobacco consumption in a Mexican population. Daily smokers were classified as light smokers (LS; n = 742), heavy smokers (HS; n = 601) and nonsmokers (NS; n = 606). In the first stage, a genotyping microarray that included 347 SNPs in and genes and 37 ancestry-informative markers was used to analyze 707 samples (187 HS, 328 LS and 192 NS). In the second stage, 14 SNPs from stage 1 were validated in the remaining samples (HS, LS and NS; n = 414 in each group) using real-time PCR. To predict the role of the associated SNPs, an in silico analysis was performed. Two SNPs in and two in were associated with cigarette consumption, while rs10865246/C ( ) was associated with high nicotine addiction. The in silico analysis revealed that rs1882296/T had a high level of homology with Hsa-miR-6740-5p, which encodes a putative miRNA that targets glutamate receptor subunits ( ) and GABA receptor subunits ( ), while rs1882296/C had a high level of homology with Hsa-miR-6866-5p, which encodes a different miRNA that targets and . In a Mexican Mestizo population, greater consumption of cigarettes was influenced by polymorphisms in the and genes. We proposed new hypotheses regarding the putative roles of miRNAs that influence the GABAergic and glutamatergic pathways in smoking addiction.

Over the last 2 decades, virtual reality technologies (VRTs) have been proposed as a way to enhance and improve smoking cessation therapy. This systematic review aims to evaluate and summarize the current knowledge on the application of VRT in various smoking cessation therapies, as well as to explore potential directions for future research and intervention development. A literature review of smoking interventions using VRT was conducted. Not all intervention studies included an alternative therapy or a placebo condition against which the effectiveness of the intervention could be benchmarked, or a follow-up measure to ensure that the effects were lasting. Virtual reality (VR) cue exposure therapy was the most extensively studied intervention, but its effect on long-term smoking behavior was inconsistent. Behavioral therapies such as a VR approach-avoidance task or gamified interventions were less common but reported positive results. Notably, only 1 study combined Electronic Nicotine Delivery Devices with VRT. The inclusion of a behavioral component, as is done in the VR approach-avoidance task and gamified interventions, may be an interesting avenue for future research on smoking interventions. As Electronic Nicotine Delivery Devices are still the subject of much controversy, their potential to support smoking cessation remains unclear. For future research, behavioral or multicomponent interventions are promising avenues of exploration. Future studies should improve their validity by comparing their intervention group with at least 1 alternative or placebo control group, as well as incorporating follow-up measures.